Drug Patent Expirations for the week of May 20, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| ACTONEL WITH CALCIUM (COPACKAGED) | Warner Chilcott | calcium carbonate; risedronate sodium | 6,096,342*PED | May 21, 2012 | |||||
| IMODIUM MULTI-SYMPTOM RELIEF | Mcneil | loperamide hydrochloride; simethicone | 5,716,641 | May 21, 2012 | |||||
| VIRAMUNE | Boehringer Ingelheim | nevirapine | 5,366,972*PED | May 22, 2012 | |||||
| ACTONEL | Warner Chilcott | risedronate sodium | 6,096,342*PED | May 22, 2012 | |||||
| VIRAMUNE XR | Boehringer Ingelheim | nevirapine | 5,366,972*PED | May 22, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment